A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings
Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19 disease. RT-qPCR has been the primary method of diagnosis; however, the required infrastructure is lacking in many developing countries and the virus has remained a global challenge. More inexpen...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5bca0fb6db4f425babdb323db478f1a8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5bca0fb6db4f425babdb323db478f1a8 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5bca0fb6db4f425babdb323db478f1a82021-11-28T12:19:29ZA SARS-CoV-2 antigen rapid diagnostic test for resource limited settings10.1038/s41598-021-02128-y2045-2322https://doaj.org/article/5bca0fb6db4f425babdb323db478f1a82021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-02128-yhttps://doaj.org/toc/2045-2322Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19 disease. RT-qPCR has been the primary method of diagnosis; however, the required infrastructure is lacking in many developing countries and the virus has remained a global challenge. More inexpensive and immediate test methods are required to facilitate local, regional, and national management strategies to re-open world economies. Here we have developed a SARS-CoV-2 antigen test in an inexpensive lateral flow format to generate a chromatographic result identifying the presence of the SARS-CoV-2 antigen, and thus an active infection, within a patient anterior nares swab sample. Our 15-min test requires no equipment or laboratory infrastructure to administer with a limit of detection of 2.0 × 102 TCID50/mL and 87.5% sensitivity, 100% specificity when tested against 40 known positive and 40 known negative patient samples established by a validated RT-qPCR test.Erica FrewDouglas RobertsShelly BarryMatthew HoldenAmanda Restell MandEmily MitsockEnqing TanWei YuJohan SkogNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Erica Frew Douglas Roberts Shelly Barry Matthew Holden Amanda Restell Mand Emily Mitsock Enqing Tan Wei Yu Johan Skog A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings |
description |
Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19 disease. RT-qPCR has been the primary method of diagnosis; however, the required infrastructure is lacking in many developing countries and the virus has remained a global challenge. More inexpensive and immediate test methods are required to facilitate local, regional, and national management strategies to re-open world economies. Here we have developed a SARS-CoV-2 antigen test in an inexpensive lateral flow format to generate a chromatographic result identifying the presence of the SARS-CoV-2 antigen, and thus an active infection, within a patient anterior nares swab sample. Our 15-min test requires no equipment or laboratory infrastructure to administer with a limit of detection of 2.0 × 102 TCID50/mL and 87.5% sensitivity, 100% specificity when tested against 40 known positive and 40 known negative patient samples established by a validated RT-qPCR test. |
format |
article |
author |
Erica Frew Douglas Roberts Shelly Barry Matthew Holden Amanda Restell Mand Emily Mitsock Enqing Tan Wei Yu Johan Skog |
author_facet |
Erica Frew Douglas Roberts Shelly Barry Matthew Holden Amanda Restell Mand Emily Mitsock Enqing Tan Wei Yu Johan Skog |
author_sort |
Erica Frew |
title |
A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings |
title_short |
A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings |
title_full |
A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings |
title_fullStr |
A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings |
title_full_unstemmed |
A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings |
title_sort |
sars-cov-2 antigen rapid diagnostic test for resource limited settings |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/5bca0fb6db4f425babdb323db478f1a8 |
work_keys_str_mv |
AT ericafrew asarscov2antigenrapiddiagnostictestforresourcelimitedsettings AT douglasroberts asarscov2antigenrapiddiagnostictestforresourcelimitedsettings AT shellybarry asarscov2antigenrapiddiagnostictestforresourcelimitedsettings AT matthewholden asarscov2antigenrapiddiagnostictestforresourcelimitedsettings AT amandarestellmand asarscov2antigenrapiddiagnostictestforresourcelimitedsettings AT emilymitsock asarscov2antigenrapiddiagnostictestforresourcelimitedsettings AT enqingtan asarscov2antigenrapiddiagnostictestforresourcelimitedsettings AT weiyu asarscov2antigenrapiddiagnostictestforresourcelimitedsettings AT johanskog asarscov2antigenrapiddiagnostictestforresourcelimitedsettings AT ericafrew sarscov2antigenrapiddiagnostictestforresourcelimitedsettings AT douglasroberts sarscov2antigenrapiddiagnostictestforresourcelimitedsettings AT shellybarry sarscov2antigenrapiddiagnostictestforresourcelimitedsettings AT matthewholden sarscov2antigenrapiddiagnostictestforresourcelimitedsettings AT amandarestellmand sarscov2antigenrapiddiagnostictestforresourcelimitedsettings AT emilymitsock sarscov2antigenrapiddiagnostictestforresourcelimitedsettings AT enqingtan sarscov2antigenrapiddiagnostictestforresourcelimitedsettings AT weiyu sarscov2antigenrapiddiagnostictestforresourcelimitedsettings AT johanskog sarscov2antigenrapiddiagnostictestforresourcelimitedsettings |
_version_ |
1718408078955642880 |